NovaBridge Biosciences (NBP) EBT Margin (2020 - 2023)
NovaBridge Biosciences (NBP) reported EBT Margin of 2609.84% for Q3 2023, up 84.94% on a QoQ basis from 17332.08% in Q2 2023.
NovaBridge Biosciences (NBP) has 2 years of EBT Margin data on file, last reported at 2609.84% in Q3 2023.
- Quarterly EBT Margin changed N/A year-over-year to 2609.84% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 2028.34% (changed N/A YoY) and the FY2023 annual result came in at 2141.4%, up 695596.0% from the prior year.
- EBT Margin rose to 2609.84% in Q3 2023 per NBP's latest filing, from 17332.08% in the prior quarter.
- Across five years, EBT Margin topped out at 388849.08% in Q4 2020 and bottomed at 17332.08% in Q2 2023.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -2,609.84% |
| Jun 30, 2023 | -17,332.08% |
| Dec 31, 2020 | 388,849.08% |